Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

Shares of Medtronic (NYSE: MDT ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and automatically adjust insulin ...

Growth potential rests heavily on the diabetes segment, where the MiniMed 780G ... think that Medtronic is positioned to dominate. As always, there are also questions of cost (insulin pens are ...